DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Moore MJ, Goldstein D, Hamm J. et al.
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.
J Clin Oncol 2007; 25: 1960-1966
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.